ATE142789T1 - Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür - Google Patents

Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür

Info

Publication number
ATE142789T1
ATE142789T1 AT90915194T AT90915194T ATE142789T1 AT E142789 T1 ATE142789 T1 AT E142789T1 AT 90915194 T AT90915194 T AT 90915194T AT 90915194 T AT90915194 T AT 90915194T AT E142789 T1 ATE142789 T1 AT E142789T1
Authority
AT
Austria
Prior art keywords
antibodies
binding
carrier
antiphospholipide
kit
Prior art date
Application number
AT90915194T
Other languages
English (en)
Inventor
Eiji Matsuura
Yoshiko Igarashi
Hisato Nagae
Original Assignee
Yamasa Shoyu Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu Kk filed Critical Yamasa Shoyu Kk
Application granted granted Critical
Publication of ATE142789T1 publication Critical patent/ATE142789T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90915194T 1989-10-19 1990-10-19 Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür ATE142789T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27253689 1989-10-19
JP7496090 1990-03-23
JP18587090 1990-07-13

Publications (1)

Publication Number Publication Date
ATE142789T1 true ATE142789T1 (de) 1996-09-15

Family

ID=27301664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90915194T ATE142789T1 (de) 1989-10-19 1990-10-19 Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür

Country Status (8)

Country Link
US (1) US5506110A (de)
EP (1) EP0450099B1 (de)
AT (1) ATE142789T1 (de)
AU (1) AU640699B2 (de)
CA (1) CA2044142A1 (de)
DE (1) DE69028513T2 (de)
NZ (1) NZ237535A (de)
WO (1) WO1991006006A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644163B2 (en) * 1990-04-06 1993-12-02 Yamasa Shoyu Co. Ltd. Methods for determining phospholipids and antibodies thereof
WO1992021981A1 (en) * 1991-05-29 1992-12-10 Baxter International Inc. Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
CA2176007A1 (en) * 1993-11-16 1995-05-26 Eiji Matsuura Method of assaying antiphospholipid antibody and kit therefor
DE69525226T2 (de) * 1994-11-25 2002-06-27 Kyoto Daiichi Kagaku Co. Ltd., Kyoto Vorrichtung und Verfahren zur Bestimmung von Wasserstoffperoxid
US6410775B1 (en) 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5874409A (en) * 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
CA2256449A1 (en) * 1996-06-06 1997-12-11 Lajolla Pharmaceutical Company Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
US6177282B1 (en) 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
CN1762990A (zh) * 1999-06-08 2006-04-26 拉卓拉药物公司 包含氨基氧基的化合价平台分子
WO2001021183A1 (en) * 1999-09-22 2001-03-29 The Liposome Company, Inc. Solid phase assay
EP1292337A2 (de) * 2000-06-08 2003-03-19 La Jolla Pharmaceutical Polyethylenoxid mit hohem molekulargewicht enthaltende multivalenz-plattformmoleküle
US6777193B1 (en) * 2000-08-04 2004-08-17 Escuela Nacional De Ciencias Biologicas, Del Instituto Politecnico Nacional Methods for diagnostic and/or treatment of antiphospholipids antibodies-related diseases, and devices
GB0104057D0 (en) * 2001-02-20 2001-04-04 Babraham Inst Antiphospholipid antibody syndrome
DE10127712A1 (de) * 2001-06-07 2002-12-19 Torsten Witte Anwendung von IgM-Antikörpern gegen dsDNA beim systemischen Lupus erythematodes mit Nephritis
WO2006109312A2 (en) * 2005-04-15 2006-10-19 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
AU2006236403B2 (en) * 2005-04-18 2011-11-10 Bio-Rad Laboratories, Inc. Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment
JP4452324B2 (ja) * 2008-03-31 2010-04-21 積水メディカル株式会社 精製血清アルブミン及び免疫学的測定方法
EP3167286A1 (de) * 2014-07-07 2017-05-17 GA Generic Assays GmbH Autoantikörperprofilerstellung bei aps
CN117288948B (zh) * 2023-06-19 2024-06-04 无锡嘉润诊断技术有限公司 抗凝血酶原抗体检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668638A (en) * 1983-03-24 1987-05-26 The Liposome Company, Inc. Liposome composition for lupus assay
CA1327963C (en) * 1987-09-08 1994-03-22 Ryuichi Yokohari Autoantibody adsorbent and apparatus for removing autoantibodies using the same
EP0460097A4 (en) * 1989-02-27 1992-03-11 Biostar Med Prod Method and diagnostic test kit for detection of anti-cardiolipin
ES2079653T3 (es) * 1990-04-06 1996-01-16 Yamasa Shoyu Kk Metodos para determinar anticuerpos antifosfolipidos.
AU644163B2 (en) * 1990-04-06 1993-12-02 Yamasa Shoyu Co. Ltd. Methods for determining phospholipids and antibodies thereof

Also Published As

Publication number Publication date
DE69028513D1 (de) 1996-10-17
CA2044142A1 (en) 1991-04-20
EP0450099A4 (en) 1991-12-27
EP0450099B1 (de) 1996-09-11
US5506110A (en) 1996-04-09
AU6532190A (en) 1991-05-16
NZ237535A (en) 1993-05-26
EP0450099A1 (de) 1991-10-09
AU640699B2 (en) 1993-09-02
WO1991006006A1 (fr) 1991-05-02
DE69028513T2 (de) 1997-02-06

Similar Documents

Publication Publication Date Title
ATE142789T1 (de) Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
FI891012A (fi) Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi
ES548270A0 (es) Un metodo de inmunoensayo
DK0378175T3 (da) Diagnostisk påvisning under anvendelse af kimære antistoffer
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
FI903348A0 (fi) Menetelmä ligandien vapaan fraktion mittaamiseksi biologisissa nesteissä
DE69018968D1 (de) BLUTGERINNUNGSFAKTOR BETA XIIa MONOKLONALE ANTIKÖRPER UND IMMUNANALYSE.
DK232988A (da) Fremgangsmaade til immunologisk bestemmelse af aminoterminalt prokollagen peptidtype iii og antistoffer til gennemfoerelse heraf.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
DE69224631D1 (de) Bindendes protein fixierungstest.
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
NZ215143A (en) Immunoassay and test kit for aids
SE9000931L (sv) Antikroppar mot proteiner
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
DK0439797T3 (da) Et antistof mod det carboxyl-terminale peptid af rotte-somatotropin-bindende protein
KR890009417A (ko) 모노크로날 항체의 제조방법 및 그것의 이용방법
DE69333683D1 (de) Antikörper-testbesteck zur bestimmung von amylin
ES2148248T3 (es) Peptidos de la lipoproteina (a) y su utilizacion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties